ASSOCIATIONS OF IRON OVERLOAD IN AFRICA WITH HEPATOCELLULAR-CARCINOMAAND TUBERCULOSIS - STRACHAN 1929 THESIS REVISITED

Citation
Vr. Gordeuk et al., ASSOCIATIONS OF IRON OVERLOAD IN AFRICA WITH HEPATOCELLULAR-CARCINOMAAND TUBERCULOSIS - STRACHAN 1929 THESIS REVISITED, Blood, 87(8), 1996, pp. 3470-3476
Citations number
52
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
87
Issue
8
Year of publication
1996
Pages
3470 - 3476
Database
ISI
SICI code
0006-4971(1996)87:8<3470:AOIOIA>2.0.ZU;2-Y
Abstract
We analyzed data from the first study of iron overload in Africans, co nducted between 1925 and 1928, to determine whether this common condit ion is associated with death from hepatocellular carcinoma and/or tube rculosis. In the original study, necropsies were performed on 714 adul t blacks from southern Africa. Hepatic and splenic iron levels were me asured semiquantitatively in 604 subjects and one of five iron grades was assigned. We examined death from hepatocellular carcinoma or from tuberculosis and the variables of age, sex, the presence of cirrhosis or other diagnoses that might be influenced by iron status, and tissue iron grades. Nineteen percent of men and 16% of women had the highest grade of hepatic iron. After adjustment for the presence of cirrhosis , hepatic iron grade was the variable most significantly associated wi th death from hepatocellular carcinoma (P = .021). The odds of death f rom hepatocellular carcinoma in subjects with the highest grade of hep atic iron was 23.5 (95% confidence interval, 2.1 to 225) times the odd s in subjects with the three lowest grades. Splenic iron was the varia ble most significantly associated with death from tuberculosis (P < .0 001). The odds of death from tuberculosis with the highest grade of sp lenic iron was 16.9 (4.8 to 59.9) times the odds with the two lowest g rades. These findings suggest that iron overload in black Africans may be a risk factor for death from hepatocellular carcinoma and for deat h from tuberculosis. (C) 1996 by The American Society of Hematology.